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Abstract Mouse cDNA encoding for matrilin-4 was cloned and
the primary structure of this fourth member of the matrilin
family was deduced from the nucleotide sequence. The protein
precursor of 624 amino acids consists of a putative signal peptide,
two vWFA-like domains linked by four epidermal growth factor-
like modules and a potential coiled-coil K-helical oligomerization
domain at the C-terminus. The predicted Mr of the mature
protein is 66 442. Expression in lung, brain, sternum, kidney and
heart was detected by Northern blot analysis of mouse mRNA.
Additionally an alternatively spliced mRNA lacking the sequence
coding for the first vWFA domain was found in 7 weeks old mice
leading to a protein precursor of 434 amino acids and a predicted
Mr of the mature protein of 45 468.
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1. Introduction
The matrilins are a family of extracellular matrix proteins
with a multidomain structure consisting of von Willebrand
factor type A-like domains, EGF-like domains and an K-hel-
ical coiled-coil domain. The matrilins accordingly belong to
the von Willebrand factor A superfamily that consists of pro-
teins with di¡erent domain organization and a variety of func-
tions [1]. Several vWFA-like domains have been implicated in
interactions with collagen [1].
To date three matrilins have been known, cartilage matrix
protein (CMP) now alternatively named matrilin-1 [2] and the
recently cloned matrilin-2 [2] and matrilin-3 [3,4]. Matrilin-1 is
a trimer of identical ellipsoid subunits assembled via their C-
terminal extension domains in a coiled-coil K-helix [5]. Aggre-
can [6,7] and type II collagen-containing ¢brils [8] have been
proposed as binding partners for matrilin-1 and it has been
suggested that matrilin-1 might play an integrating role in
cartilage extracellular matrix organization as a bridging mol-
ecule between these two major constituents [7]. It has also
been shown that matrilin-1 can form ¢lamentous networks
independent of collagen ¢brils [9]. Matrilin-1 is expressed
only in some types of the hyaline cartilage [10] whereas ma-
trilin-2 is found in calvaria, uterus, heart, skeletal muscle,
brain and skin but not in normal cartilage [2]. The expression
patterns appear to be complementary and the tissue distribu-
tion of matrilin-3 shows similarities to that of matrilin-1 [3,4].
It has been proposed from the structural homologies and the
complementary sites of expression, that matrilin-1 and -2 may
have a similar function in di¡erent forms of extracellular ma-
trix [2]. The primary structure of matrilin-1 has been deduced
from chicken [11], man [12] and mouse [13] cDNA, that of
matrilin-2 from mouse and partially from human cDNA [2]
and that of matrilin-3 from mouse [3], chicken [4] and parti-
ally from human cDNA [3,4]. In all cases the sequence is
highly conserved between these species, with the vWFA-like
domain being most conserved and the coiled-coil the least
conserved domain. The modular structure of the three is
very similar with each containing one or two vWFA-like do-
mains, varying numbers of EGF-like domains after the N-
terminal ¢rst vWFA-like domain and a C-terminal oligomeri-
zation domain. Matrilin-2 possesses an additional unique se-
quence of 75 amino acids between the second vWFA-like
domain and the oligomerization unit and it has recently
been shown that synthetic peptides corresponding to the C-
terminal domain of matrilin-2 assemble into a three-stranded
K-helical coiled-coil [14]. Matrilin-2 and -3 have a highly pos-
itively charged stretch of amino acid residues between the
signal peptide and the ¢rst vWFA-like domain. Matrilin-3
lacks the second vWFA-like domain seen in matrilin-1 and -2.
Supposing the existence of more members of this new fam-
ily of extracellular matrix proteins, we looked for gene prod-
ucts with a similar modular structure by searching in the EST
databases. Here we report on the primary structure of matri-
lin-4 from mouse.
2. Materials and methods
2.1. Clones, 5P RACE and RT-PCR
The matrilin-4 mouse EST clones were obtained from IMAGE
consortium [15]. 5P RACE was performed with the Marathon
cDNA Ampli¢cation kit (Clontech) following manufacturers instruc-
tions using polyA-RNA prepared with the Oligotex mRNA-kit
(Quiagen) from 19 days old mouse total embryos (CD1/C57Bl/6 hy-
brids). We used the adaptor primer AP1 (Clontech) and the gene
speci¢c primer m48: 5P-GTTCATAGCGTACTGGATCGCC-3P (nt
461^440 on the cDNA sequence, Fig. 1) designed from the EST se-
quences for the ¢rst reaction and the nested adaptor primer AP2
(Clontech) and primer m48 for a semi-nested second PCR reaction.
A faint band with the highest molecular weight was eluted from the
agarose gel and used as a template in a third PCR reaction with AP2
and m48. Each PCR was performed with 40 cycles under following
conditions: 1 min 95‡C, 1 min 63‡C, 1 min 72‡C. To exclude PCR
artifacts after a total of 120 cycles of PCR we performed at least four
independent RT-PCR reactions with mRNA prepared from kidney of
adult CD1 mice to get an errorless sequence by direct sequencing of
FEBS 20872 25-9-98
0014-5793/98/$19.00 ß 1998 Federation of European Biochemical Societies. All rights reserved.
PII: S 0 0 1 4 - 5 7 9 3 ( 9 8 ) 0 1 1 1 1 - 9
*Corresponding author. Fax: +49 (221) 4786977.
E-mail: Raimund.Wagener@uni-koeln.de
Abbreviations: vWFA, von Willebrand factor type A; EGF, epidermal
growth factor; EST, expressed sequence tag; GAPDH, glyceraldehyde-
3-phosphate dehydrogenase; RT-PCR, reverse transcription polymer-
ase chain reaction; RACE, rapid amplification of cDNA ends
The nucleotide sequence reported in this paper has been submitted to
the EMBL nucleotide sequence database with accession number
AJ006140.
FEBS 20872 FEBS Letters 436 (1998) 123^127
the RT-PCR products. After reverse transcription with Superscript II
(BRL), PCR was carried out with Amplitaq (Perkin Elmer) using
primers m45, 5P-AACCATCCACCAGGAGAACAAG-3P (nt 1275^
1254) and m412, 5P-GCTCTGTAGCCGCACCTCTG-3P (nt 9^28)
for 40 cycles under following conditions: 1 min 95‡C, 1 min 63‡C,
1 min 72‡C. The RT-PCR reactions for the alternatively spliced
mRNA were performed under the same conditions.
2.2. DNA sequencing
DNA sequencing was performed on double-stranded plasmid DNA
and PCR products using the ABI Prism Big Dye Terminator Cycle
Sequencing Ready Reaction Kit and the products were resolved on an
ABI Prism 377 Automated Sequencer (Perkin-Elmer/Applied Biosys-
tems). Plasmids were sequenced two times in both directions, RT-
PCR products sequenced directly at least 4 times in both directions
to exclude PCR artifacts. Nucleotide sequence analysis was performed
with the programs of the GCG package [16].
2.3. Northern blot analysis
Total RNA of various tissues was extracted from 7 weeks old fe-
male CD1 mice by the guanidinium-thiocyanate method. PolyA-
RNA was prepared from the total RNA using the Oligotex mRNA-
kit (Quiagen). Three to six Wg aliquots of polyA-RNA were electro-
phoresed on a 1.2% denaturing agarose-formaldehyde gel, blotted and
hybridized. The conditions for the last two washing steps were:
0.1USSC, 0.1% SDS at 65‡C for 10 min each.
3. Results
3.1. Mouse matrilin-4
A search in the EST database yielded several mouse ESTs
(AA003393, AA050024, AA462743, AA030414, W65581,
AA016343, AA289820 and AA048871) with a sequence iden-
tity to the other matrilins of about 50% that could not be
attributed to one of the known matrilins. They could be ar-
ranged in two independent sets of overlapping clones. By RT-
PCR (data not shown) we could show that both sets code for
the same protein. By sequencing we found that the delivered
N-terminal ESTs (AA289820 and AA048871) were contami-
nated and did not contain the desired sequence. Sequencing of
the remaining most N-terminal EST AA003393 yielded the C-
terminal half of matrilin-4. By 5P RACE we cloned the N-
terminal half. The combined cDNA for mouse matrilin-4 cov-
ered 2193 bp (Fig. 1). The 5P untranslated sequence was 89 bp
long and the ¢rst ATG codon was followed by an open read-
ing frame of 1872 bp ending with an TGA stop codon and
229 bp 3P untranslated sequence that lacked a polyadenylation
signal. The protein predicted from the open reading frame
consisted of 624 amino acids preceded by a putative signal
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Fig. 1. Nucleotide and deduced amino acid sequences of mouse matrilin-4. nt 1^28 is from CD1/C57BL/6J hybrids, nt 29^1281 is from CD1
and nt 1282^2193 is from C57BL/6J mice. Polymorphisms: nt 1045 is A instead of C in C57BL/6J leading to aa (319) Glu instead of Ala and
nt 1126 is A instead of G in C57BL/6J leading to aa (346) Asp instead of Gly. Arrowhead, predicted propeptidase cleavage site; the potential
N-linked glycosylation sites (amino acid residues 71^73 and 307^309) are underlined.
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peptide of 21 amino acids as predicted by a method using
neural networks [17] (Fig. 1). The mature secreted protein
has a predicted Mr of 66 442 and has the characteristic do-
main structure of the matrilin family (Fig. 2). It contains two
vWFA-like domains linked by four EGF-like domains and a
putative C-terminal oligomerization domain. The identity to
mouse matrilin-1, -2 and -3 is 50.6%, 52.8% and 48.5% re-
spectively. The ¢rst vWFA-like domain (Asn71-Ala-Thr) and
the third EGF-like domain (Asn307-His-Ser) of the mouse ma-
trilin-4 contain a potential N-glycosylation site.
A sequence alignment of the di¡erent modules with their
counterparts in the other matrilins of mouse shows the strik-
ing homology (Fig. 3). The sequence identity of the ¢rst
vWFA-like domain of matrilin-4 to the ¢rst vWFA-like do-
mains of matrilin-1, -2 and -3 is 49.2%, 52.4% and 51.3%
respectively and for the second vWFA-like domain of matri-
lin-4 to the second vWFA domains of matrilin-1 and -2 is
56.0% and 58.8% respectively. The sequence identity between
both vWFA domains of matrilin-4 is 41.7%. The metal ion-
dependent adhesion site (MIDAS) motif [18], the two £anking
cysteine residues and the six hydrophobic residues that are
highly conserved in vWFA-like domains [19] are also present
in matrilin-4. The structure consists of alternating amphipatic
K-helices and hydrophobic L strands (Fig. 3A) and is in good
agreement with the structure of the vWFA-like domain of the
K subunit of the A domain of the integrins CR3 [18] and
LFA-1 [20] and the A3 domain of the von Willebrand factor
[21] which have been determined at high resolution. The four
EGF-like domains, which are characterized by the spacing of
six cysteines, have an average sequence identity with each
other of 42.0%. Comparing the EGF-like domains of matri-
lin-4 with the EGF-like domains of the other matrilins, the
identity is highest (58.5%) between the ¢rst EGF-like domain
of matrilin-4 and the second EGF-like domain of matrilin-2
and lowest (29.3%) between the third EGF-like domain of
matrilin-4 and fourth EGF-like domain of matrilin-3. The
average sequence identity with respect to the other matrilins
is 44.7%. The EGF-like domains of matrilin-4 lack the key
residues involved in Ca2-binding [22] to EGF-like domains
and do also not contain the extra amino acid residue found in
the EGF-like domains of human and mouse matrilin-3 (Fig.
3B). The potential oligomerization domain has the lowest ho-
mology to the other matrilins (Fig. 3C). While the degree of
identity is 38.2% to matrilin-1, 40.4% to matrilin-2 and only
20.7% to matrilin-3 the positions a and d of the heptad re-
peats are well conserved. The COILS program [23] detects 4.5
heptad repeats that are also found in matrilin-1 and -2. The
pair of closely spaced cysteine residues at the beginning of the
oligomerization domain is conserved in all four matrilins. In
the case of matrilin-1 it was shown that these cysteines form
interchain disul¢de bonds [24].
3.2. Alternative splicing
By RT-PCR we found an alternatively spliced mRNA in
lung, sternum, brain, kidney and heart of 7 weeks old mice
lacking 190 amino acid residues coding for the ¢rst vWFA-
like domain (Fig. 2). This splice variant was not detected in
19.5 days embryos or in 2, 8, and 21 days old animals (data
not shown). The codons G168G169T170 of aa 27 (Gly) and
G738G739G740 of aa 217 (Gly) (Fig. 1) are fused to a resulting
new GGG codon (Gly) leading to the transition nucleotide
sequence G165C166A167GGG740A741A742G743 and the corre-
sponding amino acid sequence A26GK218. The exact splice
site will be determined when the genomic sequence is known.
The alternative splicing leads to a mature protein product that
has a predicted Mr of 45 468.
3.3. Gene expression
We studied the expression of the matrilin-4 gene in di¡erent
mouse tissues by Northern hybridization with polyA-RNA
(Fig. 4). The strongest signal, a 2.7 kbp band, could be de-
tected in liver, weak signals also in brain and sternum and
very weak signals in kidney and heart. Additionally a 4.0 kbp
and a 2.45 kbp band was detected in lung, brain and sternum.
The 2.1 kbp band present in lung and very weakly in brain
was due to the di¡erentially spliced mRNA as the signal was
absent when the blot was hybridized with a probe coding for
the ¢rst vWFA-like domain alone (data not shown).
4. Discussion
We have isolated and characterized mouse cDNA for ma-
trilin-4, the fourth member of a novel family of extracellular
matrix proteins, as evidenced from the striking sequence sim-
ilarity of the protein to the other three members which are the
nearest homologues detected in the databases. Matrilin-4
shares the modular composition of vWFA-like, EGF-like
and coiled-coil domains. Although there are strong homolo-
gies between matrilin-4 and the previously known matrilins
there are clear di¡erences in the domain arrangement. The
vWFA domains and the coiled-coil domain of matrilin-4
have the highest similarity to the respective domains of ma-
trilin-2. The gene is mainly expressed in lung, where the
mRNA could be derived from bronchial cartilage but the
minor expression in brain, sternum, kidney and heart shows
that matrilin-4, as matrilin-2, is expressed also in tissues other
than cartilage. It has been proposed that matrilin-2 may have
a tissue speci¢c role similar to that of matrilin-1, which binds
to collagen ¢brils and proteoglycan in cartilage and possibly
connects these structures [2]. Similarly, matrilin-4 may take
over this role especially in lung where matrilin-2 on the basis
of Northern hybridization is not expressed [2].
The conservation of the MIDAS motif [18] in the vWFA-
like domain implies the dependence on divalent cations for
function although it has been shown recently from crystallo-
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Fig. 2. Comparison of the modular structure of the matrilin family.
The horizontal line denotes the coding region of the uncomplete
mouse matrilin-4 cDNA clone (ID 427166) [15].
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Fig. 3. Amino acid sequence alignments of the murine matrilin modules. Murine sequences were aligned by the PILEUP program of the GCG
package, using the default parameters. Matrilin-1 (CMP) [13] is numbered from the ¢rst codon identi¢ed, matrilin-2 [4], matrilin-3 [3] and ma-
trilin-4 are numbered from the ¢rst amino acid of the protein precursor. A: Sequence alignment of the vWFA-like modules. The locations of
the K-helices and L-sheets determined from averaged structure predictions of 75 modules [19] are indicated by the arrow ranges L1-K12. Struc-
ture predictions by the Chou-Fasman (CF) and Garnier (G) methods for the vWFA-like modules of matrilin-4 are shown underneath (b,
L-sheet; h, K-helix; t, turn). The conserved metal ion-dependent adhesion site [18] and the conserved hydrophobic moities [19] are denoted with
(F) or (*) respectively. B: Sequence alignment of the EGF-like modules. The conserved positions of the cysteine residues are marked by aster-
isks, the additional aspartic acid residue of the matrilin-3 EGF-like repeats is marked by an arrow. C: Sequence alignment of the K-helical
coiled-coil domains. The positions a and d of the heptad repeats are indicated above. The conserved cysteine residues at the N-terminal end of
the coiled-coil region are marked with arrows.
R. Wagener et al./FEBS Letters 436 (1998) 123^127126
graphic data of the A3 domain of the von Willebrand factor
that it must not necessarily have this function [21,25]. The
presence of heptad repeats indicates the oligomerization of
subunits via a coiled-coil K-helical structure. The number of
subunits in the oligomer cannot be predicted from the se-
quence alone. It was recently demonstrated that the exchange
of a single amino acid residue in the coiled-coil domain of
matrilin-1 leads to the assembly of a tetramer instead of a
trimer [26].
In 7 weeks old mice an alternatively spliced matrilin-4
mRNA was detected beneath the full length mRNA lacking
the sequence coding for the ¢rst vWFA-like domain. This
mRNA could not be seen in developing mice. The domain
structure of the resulting shorter form of matrilin-4 is some-
what similar to the structure of the matrilin-3 in that both
possess only one vWFA-like domain and di¡er only in the
position of the EGF-like domains. As to date nothing is
known about the binding partners of the di¡erent vWFA-
like domains of matrilin-4, the functional consequences can
not be predicted. In the case of matrilin-3 it was very recently
shown that it can form heterooligomers with matrilin-1
[27].
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Fig. 4. Distribution of matrilin-4 mRNA in various mouse tissues.
Northern hybridization of 3^6 Wg polyA-RNA from 7 weeks old
female CD1 mice. Lane 1 to 8: Skeletal muscle, brain, heart, liver,
kidney, lung, ear and sternum, respectively. The blot was hybridized
with a PCR fragment of mouse matrilin-4 cDNA (nt 8^1275) (upper
part) and subsequently with a GAPDH cDNA fragment (lower
part) to estimate the relative abundance of the matrilin-4 message.
The exposure time for the matrilin-4 autoradiography was 12 h us-
ing a phosphor imager (Molecular Dynamics). The image is overex-
posed with respect to the lane for lung to show the weak signals in
the other lanes. The spot in lane 4 is due to an artifact.
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